
Moderna announced Wednesday that it will ask the U.S. Food and Drug Administration to approve the emergency use of its COVID-19 vaccine for children under 6. The company said that its request is based on interim results from its clinical trial that showed, even when given a dose that was one-quarter as strong as the… read on > read on >